Our prior studies demonstrated that cellular response of T helper 1 (Th1) type was generated by a soluble antigenic fraction (ranging from 89.9 to 97.1 kDa) of Leishmania donovani promastigote, in treated Leishmania patients as well as hamsters and showed significant prophylactic potential against experimental visceral leishmaniasis (VL). Eighteen Th1 stimulatory proteins were identified through proteomic analysis of this subfraction, out of which 15 were developed as recombinant proteins. In the present work, we have evaluated these 15 recombinant proteins simultaneously for their comparative cellular responses in treated Leishmania patients and hamsters. Six proteins viz. elongation factor-2, enolase, aldolase, triose phosphate isomerase,...
Most of the studies for the identification of prophylactic antigens that elicit T cell responses wer...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...
Our prior studies demonstrated that cellular response of T helper 1 (Th1) type was generated by a so...
Development of a suitable vaccine against visceral leishmaniasis (VL), a fatal parasitic disease, is...
In visceral leishmaniasis, the recovery from the disease is always associated with the generation of...
Visceral leishmaniasis (VL) is one of the most important parasitic diseases with approximately 350 m...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi an...
<div><p>Th1 immune responses play an important role in controlling Visceral Leishmaniasis (VL) hence...
In visceral leishmaniasis (VL), Th1-type of immune responses play an important role which correlates...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani is a major pub...
Development of an effective immunoprophylactic agent for visceral leishmaniasis (VL) has become impe...
It is well known that a patient in clinical remission of visceral leishmaniasis (VL) remains immune ...
In visceral leishmaniasis, the recovery from the disease is always associated with the generation of...
Th1 immune responses play an important role in controlling Visceral Leishmaniasis (VL) hence, Leishm...
Most of the studies for the identification of prophylactic antigens that elicit T cell responses wer...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...
Our prior studies demonstrated that cellular response of T helper 1 (Th1) type was generated by a so...
Development of a suitable vaccine against visceral leishmaniasis (VL), a fatal parasitic disease, is...
In visceral leishmaniasis, the recovery from the disease is always associated with the generation of...
Visceral leishmaniasis (VL) is one of the most important parasitic diseases with approximately 350 m...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi an...
<div><p>Th1 immune responses play an important role in controlling Visceral Leishmaniasis (VL) hence...
In visceral leishmaniasis (VL), Th1-type of immune responses play an important role which correlates...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani is a major pub...
Development of an effective immunoprophylactic agent for visceral leishmaniasis (VL) has become impe...
It is well known that a patient in clinical remission of visceral leishmaniasis (VL) remains immune ...
In visceral leishmaniasis, the recovery from the disease is always associated with the generation of...
Th1 immune responses play an important role in controlling Visceral Leishmaniasis (VL) hence, Leishm...
Most of the studies for the identification of prophylactic antigens that elicit T cell responses wer...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...